Regulation & law · 04/09/2015Updated: 10/17/2026 · 1 min read
NIH to Grant Exclusive Patent License for Treating Mitral Valve Regurgitation
The National Institutes of Health is issuing a notice of its intention to grant a worldwide exclusive patent license to practice inventions for treating mitral valve regurgitation, as outlined in the NIH's patent policy